Table 1. Withdrawals due to adverse... | American Society of Hematology

Table 1.

Withdrawals due to adverse events

Adverse event	Year 1, no. patients (% patients)	Years 2 to 4, no. patients (% patients)
Neutropenia	9 (4.8)	6 (3.2)
Other	4 (2.1)*	1 (0.5)†
Nausea/vomiting	3 (1.6)	0
Thrombocytopenia	2 (1.1)	0
Agranulocytosis	1 (0.5)	0
Increased ALT level	1 (0.5)	0
Hepatitis	1 (0.5)	0
Arthropathy	0	1 (0.5)

Adverse event	Year 1, no. patients (% patients)	Years 2 to 4, no. patients (% patients)
Neutropenia	9 (4.8)	6 (3.2)
Other	4 (2.1)*	1 (0.5)†
Nausea/vomiting	3 (1.6)	0
Thrombocytopenia	2 (1.1)	0
Agranulocytosis	1 (0.5)	0
Increased ALT level	1 (0.5)	0
Hepatitis	1 (0.5)	0
Arthropathy	0	1 (0.5)

Hypersplenism (1), asthenia (1), and decreased neutrophil count (but not meeting criteria for neutropenia) (2).

Depression.